메뉴 건너뛰기
Genetics in Medicine
Volumn 17, Issue 1, 2015, Pages 58-62
Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: A report on the College of American Pathologists proficiency testing surveys
Author keywords

analytic sensitivity; BRCA1; BRCA2; proficiency testing; quality assurance
Indexed keywords

ACCURACY; ASHKENAZI JEW; BRCA2 GENE; BREAST CANCER; CANCER RISK; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; MOLECULAR GENETICS; REVIEW; TUMOR SUPPRESSOR GENE; CLINICAL TRIAL; FOUNDER EFFECT; GENETIC SCREENING; GENETICS; GOOD LABORATORY PRACTICE; HEALTH CARE SURVEY; JEW; MULTICENTER STUDY; MUTATION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS;
EID: 84920540580     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.77     Document Type: Review
Times cited : (16)
References (9)
  • 1
    • 84862255120 scopus 로고    scopus 로고
    • Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers
    • Finkelman BS, Rubinstein WS, Friedman S, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol 2012;30:1321-1328.
    • (2012) J Clin Oncol , vol.30 , pp. 1321-1328
    • Finkelman, B.S.1    Rubinstein, W.S.2    Friedman, S.3
  • 2
    • 0029794992 scopus 로고    scopus 로고
    • Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
    • Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996;14:185-187.
    • (1996) Nat Genet , vol.14 , pp. 185-187
    • Roa, B.B.1    Boyd, A.A.2    Volcik, K.3    Richards, C.S.4
  • 3
    • 0036409453 scopus 로고    scopus 로고
    • A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families
    • Phelan CM, Kwan E, Jack E, et al. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat 2002;20:352-357.
    • (2002) Hum Mutat , vol.20 , pp. 352-357
    • Phelan, C.M.1    Kwan, E.2    Jack, E.3
  • 4
    • 8544275871 scopus 로고    scopus 로고
    • Hereditary breast cancer in Jews
    • Rubinstein WS. Hereditary breast cancer in Jews. Fam Cancer 2004;3:249-257.
    • (2004) Fam Cancer , vol.3 , pp. 249-257
    • Rubinstein, W.S.1
  • 5
    • 79953718190 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 hereditary breast and ovarian cancer
    • Sep 4 [Updated 2013 Sep 26]. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds) [Internet]. University of Washington: Seattle, WA, 1993-2014.
    • Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 hereditary breast and ovarian cancer. 1998 Sep 4 [Updated 2013 Sep 26]. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds). GeneReviews(r) [Internet]. University of Washington: Seattle, WA, 1993-2014. http://www.ncbi.nlm.nih.gov/books/NBK1247
    • (1998) Gene Reviews(r)
    • Petrucelli, N.1    Daly, M.B.2    Feldman, G.L.3
  • 6
    • 84893635979 scopus 로고    scopus 로고
    • Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disordersr
    • CAP/ACMG Biochemical and Molecular Genetics Resource Committee
    • Richards CS, Palomaki GE, Lacbawan FL, Lyon E, Feldman GL; CAP/ACMG Biochemical and Molecular Genetics Resource Committee. Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders. Genet Med 2014;16:25-32.
    • (2014) Genet Med , vol.16 , pp. 25-32
    • Richards, C.S.1    Palomaki, G.E.2    Lacbawan, F.L.3    Lyon, E.4    Feldman, G.L.5
  • 7
    • 84920511710 scopus 로고    scopus 로고
    • Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population
    • Feldman GL, Schrijver I, Lyon E, Palomaki GE. Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population. Genet Med 2014;16:695-702.
    • (2014) Genet Med , vol.16 , pp. 695-702
    • Feldman, G.L.1    Schrijver, I.2    Lyon, E.3    Palomaki, G.E.4
  • 8
    • 85027956019 scopus 로고    scopus 로고
    • Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey
    • Palomaki GE, Richards CS. Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey. Genet Med 2012;14:69-75.
    • (2012) Genet Med , vol.14 , pp. 69-75
    • Palomaki, G.E.1    Richards, C.S.2
  • 9
    • 84857862311 scopus 로고    scopus 로고
    • Molecular genetic testing for fragile X syndrome: Laboratory performance on the College of American Pathologists proficiency surveys 2001-2009)
    • CAP/ACMG Biochemical and Molecular Genetics Resource Committee
    • Weck KE, Zehnbauer B, Datto M, Schrijver I; CAP/ACMG Biochemical and Molecular Genetics Resource Committee. Molecular genetic testing for fragile X syndrome: laboratory performance on the College of American Pathologists proficiency surveys (2001-2009). Genet Med 2012;14:306-312.
    • (2012) Genet Med , vol.14 , pp. 306-312
    • Weck, K.E.1    Zehnbauer, B.2    Datto, M.3    Schrijver, I.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.